Lv4
710 积分 2023-05-06 加入
Tumor-derived erythropoietin acts as an immunosuppressive switch in cancer immunity
3天前
已完结
Application of Antibody Fragments in ADCs
17天前
已完结
Clinical pharmacokinetics of bevacizumab in patients with solid tumors
1个月前
已完结
Therapeutic potential of cis-targeting bispecific antibodies
1个月前
已完结
Role of EGFR and FASN in breast cancer progression
2个月前
已完结
Genetic Code Expansion History and Modern Innovations
3个月前
已完结
Targeted Covalent Modification Strategies for Drugging the Undruggable Targets
3个月前
已完结
Extrachromosomal DNA in Cancer
4个月前
已完结
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
5个月前
已完结
Amivantamab plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC
5个月前
已完结
皖公网安备34019202002308
